BioCentury
ARTICLE | Clinical News

oral Debio 1450: Phase I started

June 23, 2014 7:00 AM UTC

Debiopharm began a double-blind, placebo-controlled, U.S. Phase I trial to evaluate single ascending-doses of oral Debio 1450 in up to 48 healthy subjects. An IV formulation of the product is in Phase...